For information on submitting an obituary, please contact Reading Eagle by phone at 610-371-5018, or email at obituaries@readingeagle.com or fax at 610-371-5193.
Most obituaries published in the Reading Eagle are submitted through funeral homes and cremation services, but we will accept submissions from families. Obituaries can be emailed to obituaries@readingeagle.com.
In addition to the text of the obituary, any photographs that you wish to include can be attached to this email. Please put the text of the obituary in a Word document, a Google document or in the body of the email. The Reading Eagle also requires a way to verify the death, so please include either the phone number of the funeral home or cremation service that is in charge of the deceased’s care or a photo of his/her death certificate. We also request that your full name, phone number and address are all included in this email.
All payments by families must be made with a credit card. We will send a proof of the completed obituary before we require payment. The obituary cannot run, however, until we receive payment in full.
Obituaries can be submitted for any future date, but they must be received no later than 3:00 p.m. the day prior to its running for it to be published.
Please call the obituary desk, at 610-371-5018, for information on pricing.
Phillies outfielder Johan Rojas’s 80-game suspension for use of a performance-enhancing substance was made official by the Office of the Commissioner of Baseball on Monday.
The league announced that Rojas tested positive for Boldenone, in violation of the league’s drug policy. Rojas’ suspension will begin at the start of the 2026 season. He is ineligible for the postseason this year.
In a statement, the Phillies said they, “fully support Major League Baseball’s Joint Prevention and Treatment Program and are disappointed to hear today’s news of Johan’s violation.”
Rojas’ ban was first made public two weeks ago when he abruptly left the Dominican Republic team at the World Baseball Classic after reports from the country indicated a looming positive test.
Rojas, 25, skipped from Double A straight to them majors in 2023, playing 59 games for the Phillies. He played in 120 games in 2024, then batted .224 with one homer and 18 RBIs in 71 games in the bigs last year. He hit 4-for-43 in the postseason in 2023 as a regular starter in center.
Rojas hit .279 in 35 games in Triple A last year. He was 4-for-24 with a double and two RBIs in 10 games this spring.
He’s the third Phillies to test positive for a performance-enhancing drug in the last year, joining pitcher Jose Alvarado and outfielder Max Kepler.